# Indapta Therapeutics funding: rounds and investors

> Indapta Therapeutics has raised $51M across 1 round since 2025. Investors include RA Capital Management, Vertex Ventures and Revent.

Source: https://millionrounds.com/company/indapta-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Venture startup](https://millionrounds.com/companies)

# Who invested in *Indapta Therapeutics*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summary Updated 26 Oct 2026

**$51M** raised across 1 round since 2025, from 1 source

- **Latest round:** Venture, $51M Oct 2025
- **Investors:** 4

See who backed them

## The rounds

- **Oct 2025** Venture **$51M** [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Vertex Ventures](https://millionrounds.com/fund/vertex-ventures) [Revent](https://millionrounds.com/fund/revent-2) [Red Cedar Ventures](https://millionrounds.com/fund/red-cedar-ventures) Source recorded SEC filing: $51M sold, first sale Sept 2025

## Founders and team

From Indapta Therapeutics's own website: 1 founder, 4 on the team.

**Ronald Martell** Chairman of the Board and Co-Founder, Indapta

- **Stefanie Mandl-Cashman** Acting Chief Scientific Officer
- **Andrei Shustov** Head of Clinical Development
- **Linda Barnes** Head of Regulatory & Quality
- **Guy DiPierro** Team

## Everyone who backed them

[RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round

[Vertex Ventures](https://millionrounds.com/fund/vertex-ventures) VC firm **1** round

[Revent](https://millionrounds.com/fund/revent-2) VC firm **1** round

[Red Cedar Ventures](https://millionrounds.com/fund/red-cedar-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=indapta-therapeutics).

## Also claim to have backed them

This firm lists Indapta Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Myeloma Investment Fund](https://millionrounds.com/fund/myeloma-investment-fund) Corporate VC Per its own site

## Quick answers about Indapta Therapeutics

### Who invested in Indapta Therapeutics?

Indapta Therapeutics's investors include RA Capital Management, Vertex Ventures, Revent and Red Cedar Ventures.

### How much has Indapta Therapeutics raised?

Indapta Therapeutics has raised $51M across 1 round since 2025.

### When did Indapta Therapeutics last raise?

Indapta Therapeutics's most recent round was a Venture of $51M in Oct 2025.

### What was Indapta Therapeutics's biggest round?

Its most recent round, $51M in Oct 2025, is also its largest on record.

### Who backed Indapta Therapeutics first?

Indapta Therapeutics's first round on record, in Oct 2025, was backed by RA Capital Management, Vertex Ventures and Revent and 1 others.

### What stage is Indapta Therapeutics at?

Indapta Therapeutics's latest named round is a Venture, in Oct 2025.

### Where is Indapta Therapeutics based?

Indapta Therapeutics is based in the United States.

## Companies like Indapta Therapeutics

In the same sector, and raised in the last eighteen months.

[**Matchpoint Therapeutics** $220M · Oct 2026](https://millionrounds.com/company/matchpoint-therapeutics)[**Rx Bandz** Oct 2026](https://millionrounds.com/company/rx-bandz)[**Hera Biotech** $1.8M · Sept 2026](https://millionrounds.com/company/hera-biotech)[**GevRx Nutraceuticals** $300K · Sept 2026](https://millionrounds.com/company/gevrx-nutraceuticals)[**RegCell** $81M · Sept 2026](https://millionrounds.com/company/regcell)[**ClearSight Therapeutics** $307K · Sept 2026](https://millionrounds.com/company/clearsight-therapeutics)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app